• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Kashiv Biosciences Expands Leadership Team with CFO & CLO

    BUSINESSWIRE

    Kashiv BioSciences Appoints Dr. Sandeep Nilkanth Athalye as CEO

    BUSINESSWIRE

    Kashiv Completes Phase III Enrollment For ADL018, XOLAIR Biosimilar

    BUSINESSWIRE

    Kashiv Licenses Proposed XOLAIR Biosimilar To Amneal

    BUSINESSWIRE

    Kashiv BioSciences Enrolls First Patient in Phase III Clinical Study for ADL018

    BUSINESSWIRE

    Kashiv BioSciences`s Biologic Releuko (Filgrastim) Receives Approval in the U.S.

    FDA

    Kashiv Biosciences Announces Successful Phase 1 Study Results of ADL018

    BUSINESSWIRE

    Kashiv`s Biologic Releuko (Filgrastim) Receives Approval in the U.S.

    FDA

    Kashiv Biosciences Achieves Second U.S. Biosimilar Approval with FYLNETRA

    BUSINESSWIRE

    Kashiv Biosciences` Flunetra (Pegfilgrastim-pbbk)) Receives Approval the U.S.

    FDA

    Kashiv Bio Bags Approval for Its First Biosimilar RELEUKOTM (filgrastim-ayow)

    BUSINESSWIRE

    Kashiv Biosciences` Biologic Releuko (Filgrastim) Receives Approval in the U.S.

    FDA

    Amneal Completes Acquisition of Kashiv Specialty Pharmaceuticals

    BIOSPACE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.